REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr Marek Cegielski Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Dr Marek Cegielski Sp. z o.o. Profile Updated: July 29, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Dr Marek Cegielski Sp. z o.o. is an enterprise located in Poland, with the main office in Wroclaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on February 09, 2011. 1 (2015) employees currently work for Dr Marek Cegielski Sp. z o.o.. There was a net sales revenue drop of 41.67% reported in Dr Marek Cegielski Sp. z o.o.’s latest financial highlights for 2023. Its total assets decreased by 43.29% over the same period. The enterprise’s net profit margin increased by 34.5% in 2023.

Headquarters
Ul. Teofila Lenartowicza 6
Wroclaw; Dolnoslaskie; Postal Code: 51-140

Contact Details: Purchase the Dr Marek Cegielski Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Dr Marek Cegielski Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Dr Marek Cegielski Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Dr Marek Cegielski Sp. z o.o. report to view the information.
Incorporation Date:
February 09, 2011
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Dr Marek Cegielski Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-41.67%
Total operating revenue
-64.04%
Operating profit (EBIT)
-38.25%
Net Profit (Loss) for the Period
-35.14%
Total assets
-43.29%
Total equity
-8.87%
Operating Profit Margin (ROS)
17.94%
Net Profit Margin
34.5%
Return on Equity (ROE)
-22.54%
Quick Ratio
42.67%
Cash Ratio
12.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?